Pharmaceutical Contract Manufacturing Market by Service (Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services), End-User (Big Pharma, Generic Pharmaceutical Companies, Small & Mid-Size Pharma) - Global Forecas

Pharmaceutical Contract Manufacturing Market by Service (Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services), End-User (Big Pharma, Generic Pharmaceutical Companies, Small & Mid-Size Pharma) - Global Forecast 2024-2030


The Pharmaceutical Contract Manufacturing Market size was estimated at USD 114.07 billion in 2023 and expected to reach USD 123.64 billion in 2024, at a CAGR 8.46% to reach USD 201.46 billion by 2030.

Global Pharmaceutical Contract Manufacturing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Contract Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group GmbH, Almac Group, Amgen Inc., Baxter International Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Curia Global, Inc., Danaher Corporation, Dr. Reddy’s Laboratories Ltd., Elkos Group, Evonik Industries AG, Famar Group, Fareva Group, Jubilant Pharma Limited, Kryptochem Medicament Pvt. Ltd., Lonza Group, Midas Pharma GmbH, Mitsubishi Tanabe Pharma Corporation, Nipro Group, Novartis AG, Pfizer Inc., Pidolma Healthcare, PYRAMID Laboratories, Inc., Recipharm AB, Serum Institute of India Ltd., Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Service
Biologics Manufacturing Services
Biologics API Manufacturing Services
Biologics FDF Manufacturing Services
Drug Development Services
Pharmaceutical Manufacturing Services
Pharmaceutical API Manufacturing
Capsule Manufacturing Services
Oral Liquid Manufacturing Services
Parenteral/Injectable Manufacturing Services
Tablet Manufacturing Services
Pharmaceutical FDF Manufacturing
Secondary Packaging Services
End-User
Big Pharma
Generic Pharmaceutical Companies
Small & Mid-Size Pharma
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharmaceutical Contract Manufacturing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Contract Manufacturing Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Contract Manufacturing Market?
4. What is the market share of the leading vendors in the Pharmaceutical Contract Manufacturing Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Contract Manufacturing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmaceutical Contract Manufacturing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Demand for Generics and Biological Therapies
5.1.1.2. Increasing Investments in Pharmaceutical R&D and Manufacturing
5.1.1.3. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
5.1.2. Restraints
5.1.2.1. Introduction of Serialization Standards
5.1.3. Opportunities
5.1.3.1. Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector
5.1.3.2. Growing Demand for Cell and Gene Therapies for Targeted Treatment
5.1.4. Challenges
5.1.4.1. Changing Trade Policies Between Countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pharmaceutical Contract Manufacturing Market, by Service
6.1. Introduction
6.2. Biologics Manufacturing Services
6.3.1. Biologics API Manufacturing Services
6.3.2. Biologics FDF Manufacturing Services
6.3. Drug Development Services
6.4. Pharmaceutical Manufacturing Services
6.5.1. Pharmaceutical API Manufacturing
6.5.2.1. Capsule Manufacturing Services
6.5.2.2. Oral Liquid Manufacturing Services
6.5.2.3. Parenteral/Injectable Manufacturing Services
6.5.2.4. Tablet Manufacturing Services
6.5.2. Pharmaceutical FDF Manufacturing
6.5. Secondary Packaging Services
7. Pharmaceutical Contract Manufacturing Market, by End-User
7.1. Introduction
7.2. Big Pharma
7.3. Generic Pharmaceutical Companies
7.4. Small & Mid-Size Pharma
8. Americas Pharmaceutical Contract Manufacturing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pharmaceutical Contract Manufacturing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie, Inc.
12.1.2. Aenova Group GmbH
12.1.3. Almac Group
12.1.4. Amgen Inc.
12.1.5. Baxter International Inc.
12.1.6. Biozoc Inc.
12.1.7. Boehringer Ingelheim International GmbH
12.1.8. Cambrex Corporation
12.1.9. Catalent, Inc.
12.1.10. Curia Global, Inc.
12.1.11. Danaher Corporation
12.1.12. Dr. Reddy’s Laboratories Ltd.
12.1.13. Elkos Group
12.1.14. Evonik Industries AG
12.1.15. Famar Group
12.1.16. Fareva Group
12.1.17. Jubilant Pharma Limited
12.1.18. Kryptochem Medicament Pvt. Ltd.
12.1.19. Lonza Group
12.1.20. Midas Pharma GmbH
12.1.21. Mitsubishi Tanabe Pharma Corporation
12.1.22. Nipro Group
12.1.23. Novartis AG
12.1.24. Pfizer Inc.
12.1.25. Pidolma Healthcare
12.1.26. PYRAMID Laboratories, Inc.
12.1.27. Recipharm AB
12.1.28. Serum Institute of India Ltd.
12.1.29. Siegfried Holding AG
12.1.30. Sycon Healthcare
12.1.31. Thermo Fisher Scientific Inc.
12.1.32. Vetter Pharma-Fertigung GmbH & Co. KG
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 7. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 8. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings